Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia

被引：33

作者：

Kasbekar, Monica ^{[1
]}

Nardi, Valentina ^{[2
]}

Dal Cin, Paola ^{[3
]}

Brunner, Andrew M. ^{[4
]}

Burke, Meghan ^{[4
]}

Chen, Yi-Bin ^{[5
]}

Connolly, Christine ^{[4
]}

Fathi, Amir T. ^{[4
]}

Foster, Julia ^{[4
]}

Macrae, Molly ^{[4
]}

McAfee, Steven L. ^{[5
]}

McGregor, Kristin ^{[6
]}

Narayan, Rupa ^{[4
]}

Ramos, Aura Y. ^{[4
]}

Som, Tina T. ^{[4
]}

Vartanian, Meghan ^{[4
]}

Friedman, Robb S. ^{[6
]}

Benhadji, Karim A. ^{[7
]}

Hobbs, Gabriela S. ^{[4
]}

机构：

[1] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

[3] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA

[4] Massachusetts Gen Hosp, Ctr Canc, Zero Emerson Pl,Off 138, Boston, MA 02114 USA

[5] Massachusetts Gen Hosp, Blood & Marrow Transplant Program, Boston, MA 02114 USA

[6] Newton Wellesley Hosp, Canc Ctr, Newton, MA USA

[7] Taiho Oncol, Princeton, NJ USA

来源：

BLOOD ADVANCES | 2020年 / 4卷 / 13期

关键词：

8P11 MYELOPROLIFERATIVE SYNDROME; PDGFRB; FUSION;

D O I：

10.1182/bloodadvances.2020002308

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：3136 / 3140

页数：5

共 23 条

[1] Spectrum of Eosinophilic End-Organ Manifestations [J].

Akuthota, Praveen ;

Weller, Peter F. .

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2015, 35 (03) :403-+

[2] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].

Arber, Daniel A. ;

Orazi, Attilio ;

Hasserjian, Robert ;

Thiele, Jurgen ;

Borowitz, Michael J. ;

Le Beau, Michelle M. ;

Bloomfield, Clara D. ;

Cazzola, Mario ;

Vardiman, James W. .

BLOOD, 2016, 127 (20) :2391-2405

[3] Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 [J].

Bain, Barbara J. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05) :696-698

[4] Blood and Bone Marrow Evaluation for Eosinophilia [J].

Boyer, Daniel F. .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (10) :1060-1067

[5] Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application [J].

Chae, Young Kwang ;

Ranganath, Keerthi ;

Hammerman, Peter S. ;

Vaklavas, Christos ;

Mohindra, Nisha ;

Kalyan, Aparna ;

Matsangou, Maria ;

Costa, Ricardo ;

Carneiro, Benedito ;

Villaflor, Victoria M. ;

Cristofanilli, Massimo ;

Giles, Francis J. .

ONCOTARGET, 2017, 8 (09) :16052-16074

[6] AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family [J].

Gavine, Paul R. ;

Mooney, Lorraine ;

Kilgour, Elaine ;

Thomas, Andrew P. ;

Al-Kadhimi, Katherine ;

Beck, Sarah ;

Rooney, Claire ;

Coleman, Tanya ;

Baker, Dawn ;

Mellor, Martine J. ;

Brooks, A. Nigel ;

Klinowska, Teresa .

CANCER RESEARCH, 2012, 72 (08) :2045-2056

[7] A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloproliferative Neoplasm and an ins(8;5) [J].

Ghazzawi, Muna ;

Mehra, Varun ;

Knut, Marcin ;

Brown, Loretta ;

Tapper, William ;

Chase, Andrew ;

de lavallade, Hugues ;

Cross, Nicholas C. P. .

ACTA HAEMATOLOGICA, 2017, 138 (04) :198-200

[8] Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models [J].

Gozgit, Joseph M. ;

Wong, Matthew J. ;

Moran, Lauren ;

Wardwell, Scott ;

Mohemmad, Qurish K. ;

Narasimhan, Narayana I. ;

Shakespeare, William C. ;

Wang, Frank ;

Clackson, Tim ;

Rivera, Victor M. .

MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) :690-699

[9] 8p11 myeloproliferative syndrome: a review [J].

Jackson, Courtney C. ;

Medeiros, L. Jeffrey ;

Miranda, Roberto N. .

HUMAN PATHOLOGY, 2010, 41 (04) :461-476

[10] The 8p11 myeloproliferative syndrome:: A distinct clinical entity caused by constitutive activation of FGFR1 [J].

Macdonald, D ;

Reiter, A ;

Cross, NCP .

ACTA HAEMATOLOGICA, 2002, 107 (02) :101-107

← 1 2 3 →